OncoSec Medical Incorporated

Symbol: ONCS

NASDAQ

0.2772

USD

Market price today

  • -0.0457

    P/E Ratio

  • -0.0010

    PEG Ratio

  • 1.65M

    MRK Cap

  • 0.00%

    DIV Yield

OncoSec Medical Incorporated (ONCS) Financial Statements

On the chart you can see the default numbers in dynamics for OncoSec Medical Incorporated (ONCS). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of OncoSec Medical Incorporated, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

41.1912.34620.4
25.1
27
11.4
28.7
32
37.9
5
5.1
2.5
0
0
0

balance-sheet.row.short-term-investments

0000
0
23.2
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.inventory

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

10.252.93.22.5
3.4
1.6
1.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-current-assets

51.4415.249.222.8
28.5
28.6
12.5
29.4
33.6
38.3
5.2
5.5
2.9
0
0
0

balance-sheet.row.property-plant-equipment-net

17.975.66.46.8
1
1.3
2.4
2.8
1.8
0.6
0.2
0.1
0.1
0
0
0

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

1.480.40.40
0
0
0
0
0
0.5
1.2
1.9
2.7
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

1.480.40.40
0
0
0
0
0
0.5
1.2
1.9
2.7
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

2.290.60.30.3
0.4
0.4
0.3
0.2
0.2
0
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

21.746.67.17.1
1.4
1.6
2.7
3
2
1.1
1.3
1.9
2.8
0
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

73.1821.956.329.9
29.9
30.2
15.2
32.4
35.6
39.4
6.5
7.4
5.7
0
0
0

balance-sheet.row.account-payables

0000
0
0
3.3
0
0
1.2
0.7
0.4
0.4
0
0
0

balance-sheet.row.short-term-debt

6.2222.11.5
0.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

14.194.15.26.4
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

19.244.65.98.2
4.9
5.8
0.1
3.5
2.9
0.1
1
1.6
6.2
0
0
0

balance-sheet.row.total-non-current-liabilities

34.199.110.26.4
0.6
1.5
1.1
0.9
0
1.2
0.7
1
1.5
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
-1.2
-0.7
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

16.395.26.16.4
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

59.6515.818.216
5.6
7.3
4.5
4.4
2.9
1.3
1.8
3
8
0
0
0

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0.01000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

-1158.6-286-251.8-206.6
-164.4
-134.1
-94.9
-73.5
-46.6
-25.4
-13.4
-6.2
-3.8
-0.1
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

1.480.2-0.10
0.2
0
0
-0.4
-0.3
-0.1
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

1170.65291.8289.9220.5
188.5
157
105.6
101522492
79276.8
63406.6
18.1
10.6
1.5
0
0
0

balance-sheet.row.total-stockholders-equity

13.546.138.113.9
24.3
22.9
10.7
28.1
32.7
38.1
4.7
4.4
-2.4
0
0
0

balance-sheet.row.total-liabilities-and-stockholders-equity

73.1821.956.329.9
29.9
30.2
15.2
32.4
35.6
39.4
6.5
7.4
5.7
0
0
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

13.546.138.113.9
24.3
22.9
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

73.18---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
23.2
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

20.416.27.37.8
0.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

-20.78-6.1-38.6-12.5
-25.1
-3.8
-11.4
-28.7
-32
-37.9
-5
-5.1
-2.5
0
0
0

Cash Flow Statement

The financial landscape of OncoSec Medical Incorporated has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

-29.39-34.2-45.2-42.3
-30.3
-39.1
-21.4
-26.9
-21.2
-12
-7.2
-2.4
-3.8
0
0
0

cash-flows.row.depreciation-and-amortization

0.941.11.11
0.2
0.3
0.4
0.4
0.7
0.8
0.7
0.7
0.3
0
0
0

cash-flows.row.deferred-income-tax

00-0.8-0.1
0.2
0
0
0
0
0
0
0
-67.8
0
0
0

cash-flows.row.stock-based-compensation

1.281.65.13.5
3.5
8.3
4
6.1
2.6
1.8
0.5
0.3
67.8
0
0
0

cash-flows.row.change-in-working-capital

2.05-1.2-2.53.8
-3.5
2.2
-0.3
2.3
0.3
0.3
0.3
0
0.2
0
0
0

cash-flows.row.account-receivables

0000
0
0
0
0
0
0
0
0
-391.2
0
0
0

cash-flows.row.inventory

0000
0
0
0
0
0
0
0
0
38
0
0
0

cash-flows.row.account-payables

-1.38-1.4-2.63.6
-0.7
0
-0.2
0.9
1.1
0.7
0.3
0
353.2
0
0
0

cash-flows.row.other-working-capital

3.430.20.10.2
-2.8
2.2
-0.1
1.5
-0.8
-0.4
0
0
0.2
0
0
0

cash-flows.row.other-non-cash-items

0.120.60.50.9
0.8
5.2
0
0.3
0.1
0.2
0.1
-2.9
2
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

-24.99000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-0.24-0.2-0.80
0
-0.1
0
-1.6
-1.4
-0.5
-0.1
-0.1
-0.3
0
0
0

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
-25.5
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
23.2
2.3
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

-0.26-0.2-0.80
23.2
-23.3
0
-1.6
-1.4
-0.5
-0.1
-0.1
-0.3
0
0
0

cash-flows.row.debt-repayment

-1.15-1.3-0.6-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0.04062.830
27.9
32.3
0
17.5
13.6
27.9
7.2
7.8
4.1
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

4.650.16-1.5
-0.6
6.6
0.1
-1.4
-0.3
14.4
-1.7
-0.8
0
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

3.54-1.268.228.4
27.2
38.9
0.1
16.1
13.3
42.4
5.5
7
4.1
0
0
0

cash-flows.row.effect-of-forex-changes-on-cash

-0.08-0.100
-0.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-21.55-33.725.6-4.8
21.3
-7.6
-17.3
-3.3
-5.8
32.9
-0.2
2.7
2.5
0
0
0

cash-flows.row.cash-at-end-of-period

41.1912.34620.4
25.1
3.8
11.4
28.7
32
37.9
5
5.1
2.5
0
0
0

cash-flows.row.cash-at-beginning-of-period

62.744620.425.1
3.8
11.4
28.7
32
37.9
5
5.1
2.5
0
0
0
0

cash-flows.row.operating-cash-flow

-24.99-32.1-41.8-33.1
-29
-23.2
-17.3
-17.8
-17.7
-9
-5.5
-4.2
-1.3
0
0
0

cash-flows.row.capital-expenditure

-0.24-0.2-0.80
0
-0.1
0
-1.6
-1.4
-0.5
-0.1
-0.1
-0.3
0
0
0

cash-flows.row.free-cash-flow

-25.24-32.4-42.6-33.1
-29
-23.3
-17.4
-19.4
-19.1
-9.5
-5.6
-4.3
-1.6
0
0
0

Income Statement Row

OncoSec Medical Incorporated's revenue saw a change of NaN% compared with the previous period. The gross profit of ONCS is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.cost-of-revenue

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

21.77---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

10.88---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0.06000.2
0.4
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

32.653748.443.4
30.4
36.1
21.4
26.9
21.2
11.9
7.1
5.5
1.7
0
0
0

income-statement-row.row.cost-and-expenses

32.653748.443.4
30.4
36.1
21.4
26.9
21.2
11.9
7.1
5.5
1.7
0
0
0

income-statement-row.row.interest-income

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

0.05000
0
6.4
0
0
0
0
0.1
-3.2
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-0.07-0.50.80.3
0.1
-3
0
0
0
0
-0.1
3.2
-2.1
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0.06000.2
0.4
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

-0.07-0.50.80.3
0.1
-3
0
0
0
0
-0.1
3.2
-2.1
0
0
0

income-statement-row.row.interest-expense

0.05000
0
6.4
0
0
0
0
0.1
-3.2
0
0
0
0

income-statement-row.row.depreciation-and-amortization

0.991.11.11.2
0.7
3.7
0.4
0.4
0.7
0.8
0.7
0.7
0.3
0
0
0

income-statement-row.row.ebitda-caps

-31.66---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-32.65-37-48.4-43.4
-30.4
-36.1
-21.4
-26.9
-21.2
-11.9
-7.1
-5.5
-1.7
0
0
0

income-statement-row.row.income-before-tax

-32.72-37.5-47.6-43.1
-30.3
-39.1
-21.4
-26.9
-21.2
-12
-7.1
-2.4
-3.8
0
0
0

income-statement-row.row.income-tax-expense

-2.58-3.3-2.4-0.9
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.net-income

-30.14-34.2-45.2-42.3
-30.3
-39.1
-21.4
-26.9
-21.2
-12
-7.2
-2.4
-3.8
0
0
0

Frequently Asked Question

What is OncoSec Medical Incorporated (ONCS) total assets?

OncoSec Medical Incorporated (ONCS) total assets is 21878368.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.000.

What is company free cash flow?

The free cash flow is -4.923.

What is enterprise net profit margin?

The net profit margin is 0.000.

What is firm total revenue?

The total revenue is 0.000.

What is OncoSec Medical Incorporated (ONCS) net profit (net income)?

The net profit (net income) is -34179634.000.

What is firm total debt?

The total debt is 6174765.000.

What is operating expences number?

The operating expences are 37012062.000.

What is company cash figure?

Enretprise cash is 3683330.000.